| Class | CCY | SZE(M) | WAL | MO | SP | FI | DR | KR | C/E | LTV | TYPE | BNCH | GDNC | SPRD | CPN | YLD | PRICE |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | USD | 421.000 | 5.70 | Aaa | - | - | - | - | - | - | Floating | 3mL | - | - | 3mL+135 | - | - |
| B | USD | 24.500 | 7.40 | Aa2 | AA | - | - | - | - | - | Floating | 3mL | - | - | 3mL+300 | - | - |
| C | USD | 24.500 | 7.60 | A2 | A | - | - | - | - | - | Floating | 3mL | - | - | 3mL+450 | - | - |
| D | USD | 22.000 | 7.60 | Baa2 | BBB | - | - | - | - | - | Floating | 3mL | - | - | 3mL+550 | - | - |
| E | USD | 16.500 | 7.80 | Ba2 | BB | - | - | - | - | - | Floating | 3mL | - | - | 3mL+750 | - | - |
| Equity | USD | 41.500 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Explore all other research.